Target intelligence / Profile preview

Multiple Endogenous Signaling Pathways

Molecular classification
Other
01

Overview

Multiple Endogenous Signaling Pathways refers to the integrated networks of molecular interactions, such as the MAPK/ERK or PI3K/Akt pathways, that transmit external stimuli to elicit specific cellular responses (National Human Genome Research Institute, 2024). These pathways are essential for maintaining homeostasis and regulating fundamental biological processes including growth, metabolism, and apoptosis (Cooper, 2000). Because this term represents a broad category of biological activity rather than a discrete molecular entity like a receptor or enzyme, it is not classified as a specific therapeutic target (Santos et al., 2017). In drug development, specificity is required to ensure that a molecule interacts with a defined target to produce a predictable clinical outcome (Overington et al., 2006). Consequently, while multiple pathways may be dysregulated in complex diseases like cancer or chronic inflammation, therapeutic intervention focuses on modulating specific components within these networks to improve efficacy and reduce systemic toxicity.

Other names
Endogenous signaling networksCellular signaling cascadesIntracellular signaling pathways
02

Mechanism of action

Not applicable as this is a collective term for various biological processes rather than a single drug target.

03

Biological functions

Signal transductionCellular homeostasisCell communicationMetabolic regulation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseMetabolic disorders
05

Safety considerations

Lack of therapeutic specificityPotential for widespread systemic toxicityUnpredictable pleiotropic effectsCompensatory pathway activation

Beyond the preview

Go deeper on Multiple Endogenous Signaling Pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple Endogenous Signaling Pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call